Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in cirrhosis with portal vein thrombosis
2016-003240-37Phase 2Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of rivaroxaban in Cirrhosis and portal vein thrombosis (PVT) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoints: Transplant-free survival without decompensation, bleeding, or thrombosis progression and Portal vein thrombosis recanalization. Started Dec 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Cirrhosisportal vein thrombosis (PVT)
Beyond the preview
Go deeper on 2016-003240-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003240-37.